Eliana Merle
Stock Analyst at Barclays
(3.84)
# 2,159
Out of 4,698 analysts
409
Total ratings
50.3%
Success rate
4.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $43 → $32 | $14.85 | +115.49% | 7 | Sep 4, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $450 | $264.50 | +70.13% | 17 | Sep 1, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $90 | $58.13 | +54.83% | 23 | Sep 1, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $157 | $75.41 | +108.20% | 21 | Aug 31, 2026 | |
| MRNA Moderna | Maintained: Hold | $48 → $125 | $148.87 | -16.03% | 32 | Aug 24, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $105 → $111 | $66.43 | +67.09% | 42 | Aug 17, 2026 | |
| ALT Altimmune | Maintained: Buy | $20 | $3.23 | +519.20% | 8 | Aug 13, 2026 | |
| PTCT PTC Therapeutics | Maintained: Buy | $120 → $122 | $71.40 | +70.87% | 14 | Aug 13, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $345 → $329 | $271.12 | +21.35% | 14 | Aug 13, 2026 | |
| INSM Insmed | Maintained: Buy | $237 | $126.68 | +87.09% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $22.99 | -13.01% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $9.20 | +30.43% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $3.72 | +249.46% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $88 | $61.42 | +43.28% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $133 → $139 | $117.28 | +18.52% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $917 | $843.47 | +8.72% | 5 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $615 → $617 | $557.96 | +10.58% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $964 → $962 | $542.61 | +77.29% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 → $60 | $44.86 | +33.75% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.28 | $0.1756 | +59.45% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $4.84 | +271.90% | 4 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 | $24.86 | +137.33% | 8 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $10.92 | -26.74% | 4 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $14.70 | +124.49% | 1 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $115 → $117 | $102.88 | +13.72% | 25 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 → $20 | $57.46 | n/a | 25 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 → $112 | $151.22 | n/a | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $63 → $12 | $86.49 | n/a | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.92 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $21 | $9.31 | n/a | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $2.2 | $4.11 | n/a | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 | $210.87 | n/a | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $36.36 | n/a | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $14.38 | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $9.12 | n/a | 3 | Mar 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $192 → $134 | $29.02 | n/a | 10 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $2.09 | n/a | 8 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.63 | n/a | 4 | Mar 18, 2019 |
Ultragenyx Pharmaceutical
Sep 4, 2026
Maintained: Buy
Price Target: $43 → $32
Current: $14.85
Upside: +115.49%
Alnylam Pharmaceuticals
Sep 1, 2026
Maintained: Buy
Price Target: $450
Current: $264.50
Upside: +70.13%
Ionis Pharmaceuticals
Sep 1, 2026
Maintained: Buy
Price Target: $90
Current: $58.13
Upside: +54.83%
BridgeBio Pharma
Aug 31, 2026
Maintained: Buy
Price Target: $157
Current: $75.41
Upside: +108.20%
Moderna
Aug 24, 2026
Maintained: Hold
Price Target: $48 → $125
Current: $148.87
Upside: -16.03%
BioMarin Pharmaceutical
Aug 17, 2026
Maintained: Buy
Price Target: $105 → $111
Current: $66.43
Upside: +67.09%
Altimmune
Aug 13, 2026
Maintained: Buy
Price Target: $20
Current: $3.23
Upside: +519.20%
PTC Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $120 → $122
Current: $71.40
Upside: +70.87%
Ascendis Pharma
Aug 13, 2026
Maintained: Buy
Price Target: $345 → $329
Current: $271.12
Upside: +21.35%
Insmed
Aug 7, 2026
Maintained: Buy
Price Target: $237
Current: $126.68
Upside: +87.09%
Aug 7, 2026
Maintained: Hold
Price Target: $20
Current: $22.99
Upside: -13.01%
Aug 7, 2026
Downgraded: Hold
Price Target: $12
Current: $9.20
Upside: +30.43%
Aug 7, 2026
Maintained: Buy
Price Target: $13
Current: $3.72
Upside: +249.46%
Aug 7, 2026
Maintained: Buy
Price Target: $70 → $88
Current: $61.42
Upside: +43.28%
Aug 6, 2026
Maintained: Buy
Price Target: $133 → $139
Current: $117.28
Upside: +18.52%
Aug 5, 2026
Maintained: Buy
Price Target: $917
Current: $843.47
Upside: +8.72%
Aug 5, 2026
Maintained: Buy
Price Target: $615 → $617
Current: $557.96
Upside: +10.58%
Aug 3, 2026
Maintained: Buy
Price Target: $964 → $962
Current: $542.61
Upside: +77.29%
Jul 30, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $44.86
Upside: +33.75%
Jul 28, 2026
Maintained: Sell
Price Target: $0.28
Current: $0.1756
Upside: +59.45%
Jun 4, 2026
Maintained: Buy
Price Target: $18
Current: $4.84
Upside: +271.90%
Jun 3, 2026
Maintained: Buy
Price Target: $59
Current: $24.86
Upside: +137.33%
Apr 2, 2026
Maintained: Hold
Price Target: $8
Current: $10.92
Upside: -26.74%
Jan 27, 2026
Maintained: Buy
Price Target: $33
Current: $14.70
Upside: +124.49%
Nov 6, 2025
Maintained: Hold
Price Target: $115 → $117
Current: $102.88
Upside: +13.72%
Aug 12, 2025
Maintained: Hold
Price Target: $33 → $20
Current: $57.46
Upside: n/a
Aug 8, 2025
Maintained: Hold
Price Target: $96 → $112
Current: $151.22
Upside: n/a
Jul 21, 2025
Downgraded: Hold
Price Target: $63 → $12
Current: $86.49
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: $8
Current: $1.92
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: $74 → $21
Current: $9.31
Upside: n/a
Jan 28, 2025
Maintained: Hold
Price Target: $5 → $2.2
Current: $4.11
Upside: n/a
Jan 8, 2025
Maintained: Buy
Price Target: $71
Current: $210.87
Upside: n/a
Apr 4, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $36.36
Upside: n/a
Oct 13, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $14.38
Upside: n/a
Mar 3, 2021
Reiterated: Buy
Price Target: $10
Current: $9.12
Upside: n/a
Aug 19, 2020
Maintained: Hold
Price Target: $192 → $134
Current: $29.02
Upside: n/a
Dec 11, 2019
Maintained: Buy
Price Target: $40
Current: $2.09
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $8
Current: $4.63
Upside: n/a